ROC analysis revealed that the proportion of CD4+ and its subpopulation could distinguish GIR from PIR, while PIR patients are associated with higher incidence of EBV reactivation and PTLD, suggested that early CD4+ reconstitution may predict EBV infection post-transplantation. This evidence concerns the gene CD4 and post-transplant lymphoproliferative disease.